These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6119869)

  • 61. Prenalterol in symptomatic sinus node dysfunction.
    Feleke E; Rydén L; Smedgård P; Westerling S
    Am Heart J; 1985 Jan; 109(1):185-7. PubMed ID: 2857060
    [No Abstract]   [Full Text] [Related]  

  • 62. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
    Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E
    Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prenalterol, a non-selective beta-adrenoceptor ligand with absolute beta1-selective partial agonist activity.
    Hedberg A; Mattsson H; Carlsson E
    J Pharm Pharmacol; 1980 Sep; 32(9):660-1. PubMed ID: 6107374
    [No Abstract]   [Full Text] [Related]  

  • 64. [Effects of selective beta adrenergic block on myocardial contractility. Relative role of negative inotropic and chronotropic effects].
    Bardet J; Rigaud M; Rocha P; Bourdarias JP; Mathivat A
    Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1169-79. PubMed ID: 4218730
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of prenalterol on central hemodynamics and myocardial metabolism in experimental propoxyphene-induced shock.
    Häggmark S; Strøm J; Reiz S; Nyhman H; Angelo H; Sloth Madsen P; Bredgaard Sørensen M
    Acta Anaesthesiol Scand; 1987 Jan; 31(1):52-6. PubMed ID: 3825476
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
    Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
    Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
    [No Abstract]   [Full Text] [Related]  

  • 67. Chronic infarction decreases maximum cardiac work and sensitivity of heart to extracellular calcium.
    Fellenius E; Hansen CA; Mjøs O; Neely JR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H80-7. PubMed ID: 2861751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
    Awan NA; Needham KE; Evenson MK; Win A; Mason DT
    Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
    Glover DR; Wathen CG; Murray RG; Petch MC; Muir AL; Littler WA
    Br Heart J; 1985 Feb; 53(2):208-15. PubMed ID: 2857088
    [TBL] [Abstract][Full Text] [Related]  

  • 70. What is the role of positive inotropic agents in the treatment of acute myocardial infarction?
    Mason DT; Amsterdam EA; Miller RR; Williams DO
    Cardiovasc Clin; 1977; 8(1):113-22. PubMed ID: 849585
    [No Abstract]   [Full Text] [Related]  

  • 71. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
    Zilcher H
    Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute effects of beta 1 agonism with prenalterol on catecholamine circulating levels in patients with congestive heart failure.
    Corea L; Bentivoglio M; Verdecchia P; Provvidenza M
    G Ital Cardiol; 1983 Nov; 13(11):330-4. PubMed ID: 6141975
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers.
    Svendsen TL; Hartling OJ; Trap-Jensen J
    Eur J Clin Pharmacol; 1980 Oct; 18(3):219-23. PubMed ID: 6108219
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of effect of prenalterol on dialysis-associated hypotension.
    Ladefoged J
    Eur J Clin Pharmacol; 1984; 26(3):399-400. PubMed ID: 6145594
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.
    Rönn O; Fellenius E; Graffner C; Johnsson G; Lundborg P; Svensson L
    Eur J Clin Pharmacol; 1980 Feb; 17(2):81-6. PubMed ID: 6102914
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relative inotropic and chronotropic activity of beta-adrenoceptor stimulants in anaesthetised, areflexic dogs.
    Engel B; Einstein R; Goodman AH
    Eur J Pharmacol; 1983 Jan; 86(3-4):461-6. PubMed ID: 6131828
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A; Klein G; Bibra HV; Sauer E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
    Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
    Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of prenalterol and volume loading with dextran on haemodynamics and oxygen consumption in dogs during high epidural block with special reference to the splanchnic region.
    Greitz T; Andreen M; Irestedt L
    Acta Anaesthesiol Scand; 1985 Jan; 29(1):37-44. PubMed ID: 2579516
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
    Andersen EB; Lindskov HO; Marving J; Boesen F; Beck-Nielsen H; Hesse B
    Dan Med Bull; 1985 Jun; 32(3):194-6. PubMed ID: 2861975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.